Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

In vitro differentiation of c-myb−/− ES cells reveals that the colony forming capacity of unilineage macrophage precursors and myeloid progenitor commitment are c-Myb independent

Abstract

Mice homozygous for an inactivated c-myb allele exhibit embryonic (primitive) blood formation but die at about day 15 of gestation because of a failure to generate adult (definitive) haemopoiesis. Recently, it has been shown that commitment to definitive haemopoiesis does occur in vivo, but that some point in the subsequent development towards the differentiated lineages is compromised. Here we have asked whether it is possible to demonstrate this same distinction between the development of primitive and definitive haemopoiesis during the in vitro differentiation of c-myb null ES cells, and whether this can be used to define more precisely at which developmental stage the absence of c-Myb blocks the adult haemopoietic lineages. We investigated the kinetics of progenitor formation and commitment to differentiation using a combination of colony forming assays and analysis of RNA and surface antigen expression. Primitive unilineage macrophage and erythroid precursor commitment could develop in the absence of c-Myb. No precursors characteristic of definitive haemopoiesis were detected; nevertheless, we could show the expression of a programme of transcription and surface antigens which is consistent with the appearance of definitive progenitors blocked at an early multipotential stage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Alexander WS, Roberts AW, Nicola NA, Li R and Metcalf D. . 1996 Blood 87: 2162–2170.

  • Allen RD, Bender TP and Siu G. . 1999 Genes Dev. 13: 1073–1078.

  • Chomczynski P and Sacchi N. . 1987 Analytical Biochem. 162: 156–159.

  • Dzierzak E, Medvinsky A and de Bruijn M. . 1998 Immunology Today 19: 228–236.

  • Elefanty AG, Robb L, Birner R and Begley CG. . 1997 Blood 90: 1435–1447.

  • Elwood NJ, Zogos H, Pereira DS, Dick JE and Begley CG. . 1998 Blood 91: 3756–3765.

  • Faust N, Bonifer C, Wiles MV and Sippel AE. . 1994 DNA and Cell Biol. 13: 901–907.

  • Faust N, Huber MC, Sippel AE and Bonifer C. . 1997 Exp. Hematol. 25: 432–444.

  • Frampton J and Graf T. . 1998 ‘Transcription Factors in Eukaryotes’, Papavassiliou, AG (ed) RG Landes Co: Georgetown pp. 287–295.

  • Lipsick JS and Wang D-M. . 1999 Oncogene 18: 3047–3055.

  • Long MW and Williams N. . 1981 Blood 58: 1032–1039.

  • McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ and Maki RA. . 1996 EMBO J. 15: 5647.

  • Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AAT and Seidman JG. . 1992 Mol. Cell. Biol. 12: 2391–2395.

  • Mucenski ML, McLain K, Kier AB, Swederlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ and Potter SS. . 1991 Cell 65: 677–689.

  • Mukouyama Y-S, Chiba N, Mucenski ML, Satake M, Miyajima A, Hara T and Watanabe T. . 1999 Curr. Biol. 9: 833–836.

  • Naito M, Umeda S, Yamamoto T, Moriyama H, Umezu H, Hasgawa G and Usuda H. . 1996 J. Leukocyte Biol. 59: 133–138.

  • Nakano T, Kodama H and Honjo T. . 1994 Science 265: 1098–1101.

  • Ness SA. . 1996 Biochim. Biophys. Acta. 12: 123–139.

  • Nuez B, Michalovich D, Bygrave A, Ploemacher R and Grosveld F. . 1995 Nature 375: 316–318.

  • Oh I-H and Reddy EP. . 1999 Oncogene 18: 3017–3033.

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G and Downing JR. . 1996 Cell 84: 321–330.

  • Palis J, Robertson S, Kennedy M, Wall C and Keller G. . 1999 Development 126: 5073–5084.

  • Pevny L, Simon MC, Robertson E, Klein WH, Tsai S-F, D'Agati V, Orkin SH and Constantini F. . 1991 Nature 349: 257–260.

  • Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW and Orkin SH. . 1996 Cell 86: 47–57.

  • Ravid K, Beeler DL, Rabin MS, Ruley HE and Rosenberg RD. . 1991 Proc. Natl. Acad. Sci. USA 88: 88, 1521–1525.

  • Scott EW, Simon MC, Anastasi J and Singh H. . 1994 Science 265: 1573–1577.

  • Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC and Singh H. . 1997 Immunity 6: 437–447.

  • Shavit JA, Motohashi H, Onodera K, Akasaka J, Yamamoto M and Engel JD. . 1998 Genes & Dev. 12: 2164–2174.

  • Shivdasani R, Mayer E and Orkin SH. . 1995a Nature 373: 432–434.

  • Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ and Orkin SH. . 1995b Cell 81: 695–704.

  • Shivdasani RA, Fujiwara Y, McDevitt MA and Orkin SH. . 1997 EMBO J. 16: 3965–3973.

  • Sumner R, Crawford A, Mucenski M and Frampton J. . 2000 Oncogene 19: 3335–3342.

  • Suwabe N, Takahashi S, Nakano T and Yamamoto M. . 1998 Blood 92: 4108–4118.

  • Takahashi K, Yamamura F and Naito M. . 1989 J. Leuko. Biol. 45: 87–96.

  • Trimborn T, Gribnau J, Grosveld F and Fraser P. . 1999 Genes Dev. 13: 112–124.

  • Tsai F-Y, Keller G, Kuo FC, Weiss MJ, Chen J-Z, Rosenblatt M, Alt FW and Orkin SH. . 1994 Nature 371: 221–226.

  • Tsai F-Y and Orkin SH. . 1997 Blood 89: 3636–3643.

  • Tsang AP, Fujiwara Y, Hom DB and Orkin SH. . 1998 Genes Dev. 12: 1176–1188.

  • Visvader JE, Fujiwara Y and Orkin SH. . 1998 Genes Dev. 12: 473–479.

  • Weiss MJ, Keller G and Orkin SH. . 1994 Genes Dev. 8: 1184–1197.

  • Weston K. . 1998 Curr. Opin. Genet. Dev. 8: 76–81.

  • Wiles MV and Keller G. . 1991 Development 111: 259–267.

  • Yamada Y, Warren AJ, Dobson C, Forester A, Pannell R and Rabbitts TH. . 1998 Proc. Natl. Acad. Sci. USA 95: 3890–3895.

Download references

Acknowledgements

We thank all members of the Frampton and Bonifer labs for discussions and advice. This work was funded by the Wellcome Trust, the Candlelighter's Trust and the Leukaemia Research Fund. J Frampton is a Wellcome Trust Senior Research Fellow.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clarke, D., Vegiopoulos, A., Crawford, A. et al. In vitro differentiation of c-myb−/− ES cells reveals that the colony forming capacity of unilineage macrophage precursors and myeloid progenitor commitment are c-Myb independent. Oncogene 19, 3343–3351 (2000). https://doi.org/10.1038/sj.onc.1203661

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203661

Keywords

This article is cited by

Search

Quick links